i n t e g r i s

Integris Medtech

About Us

Overview

About Integris Medtech

1,800+

Employees

Integris Medtech is a diversified India-based global medical products and laboratory solutions company, focused on transforming healthcare through the development, manufacturing, and commercialisation of a broad portfolio of medical devices and solutions.

With a presence in over 65 countries and manufacturing facilities in India, Germany, and the Netherlands, we operate across two key business segments—Cardiovascular and Laboratory Solutions—offering a comprehensive interventional cardiology portfolio and end-to-end laboratory solutions across clinical and scientific settings, serving more than 2,000 hospitals and cathlabs, and over 9,500 laboratories.

Our Strategic Journey

16+ Years of Legacy

Segments & Geographies
Journey
Phase 1.0 2010 – 2015 Manufacturing, distribution and depth of product
Segments
🫀 Cardiovascular
Geographies
🇮🇳 India
2008
Commencement of business operations
2011
Launch of YUKON DES technology
Phase 2.0 2016 – 2020 International market
Segments
🫀 Cardiovascular – Vascular Access
Geographies
🌍 Europe, Middle East
2016
Launched portfolio for Vascular Access solutions
2018
Acquired Artic GmbH
2019
Secured investment from Everstone CapitalAcquired Translumina GmbH
Phase 3.0 2021 – 2025 Expansion of geography and product offering
Segments
Product portfolio for diverse customers (hospitals, pathology, diagnostic labs)
🔬 Lab SolutionsGDSLS
Geographies
65+ international markets
🌎 LATAM
🌏 Asia (Ex-India)
2023
Scaled manufacturing to three new plants (Dehradun ×2, Vizag)Acquired Lamed — vascular & cardiac surgery and stent graftsAcquisition of Blue Medical
2025
Acquisition of EverlifeLaunch of US FDA approved DES in India
Our Leadership

Board of Directors

Annaswamy Vaidheesh
Chairperson and Non-Executive Independent Director
Rajani Kesari
Non-Executive Independent Director
Ramesh Subrahmanian
Non-Executive Independent Director
Gurmit Singh Chugh
Non Executive Director
Punita Sharma
Non Executive Director
Avnish Mehra
Non-Executive Nominee Director
Arjun Oberoi
Non-Executive Nominee Director
Vishal Omprakash Goenka
Non-Executive Nominee Director
Probir Das
Group CEO and Executive Director
Probir Das
Group Chief Executive Officer
Hemant Sultania
Group Chief Financial Officer
Darpan Batra
Group General Counsel, Company Secretary and Compliance Officer
Raman Gandotra
Chief Executive Officer, Laboratory Solutions
Chan Char Mayn
Vice President of Operations, Laboratory Solutions
Fabian Chua Kai Jun
Director Business Developments – Laboratory Solutions
Sudipta Ghosh
Chief Executive Officer, Cardiovascular
Kewal Krishan
Chief Financial Officer, Cardiovascular
Paritosh Arora
President (India), Commercial Operations, Cardiovascular
Eric Kumpa
Managing Director, Translumina GmbH & Vice President – Operations, Cardiovascular (Europe)
Ingrid Frank
Vice President & Managing Director, LaMed GmbH
Kalyan Bhowal
Vice President – Operations, Cardiovascular (India)
Our Success

Awards & Recognitions

2025

TTPL was awarded “Highest Business Revenue in FY 49” from Ashai Intecc Co. Ltd.

2019

Chemopharm Sdn Bhd received “Rising Star Award” from Mindray.

2018

Hausen Bernstein Company Limited received “Distributor Excellence Award” from Euroimmun.

2017

TTPL secured recognition as one of the “Best Asian Healthcare Brands” by Economic Times.

2016

TTPL received certificate of recognition for “Highest Growth in Drug Eluting Stent Sales and Being the First Asian company to be rated at par with USFDA approved DES in the latest PCI Guidelines of European Society of Cardiology” and “Highest growth in Drug eluting stent sales & rated at par with USFDA approved DES in the latest PCI Guidelines of European Society of Cardiology” from National Interventional Council, an interventional arm of Cardiological Society of India.

2014

TTPL received a certificate of recognition for “Manufacturing Innovative and New Generation Drug Eluting Stent technology in India with World Class standards of Quality and Clinical Evaluation” from National Interventional Council, an interventional arm of Cardiological Society of India.

Our Capabilities

Manufacturing and R&D Facilities

Integris Medtech operates 6 manufacturing facilities across India, Germany, and the Netherlands, supported by integrated R&D centres that anchor ongoing innovation and product development.

Member Title

Member Designation

Member Description